GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Harpoon Therapeutics Inc (FRA:5HTA) » Definitions » Price-to-Funds-From-Operations

Harpoon Therapeutics (FRA:5HTA) Price-to-Funds-From-Operations : (As of May. 19, 2024)


View and export this data going back to 2019. Start your Free Trial

What is Harpoon Therapeutics Price-to-Funds-From-Operations?

Price-to-Funds-From-Operations only applies to REITs.


Harpoon Therapeutics (FRA:5HTA) Business Description

Traded in Other Exchanges
Address
131 Oyster Point Boulevard, Suite 300, South San Francisco, CA, USA, 94080
Harpoon Therapeutics Inc is a clinical-stage immunotherapy company. It is engaged in developing a novel class of T cell engagers that harness the power of the body's immune system to treat patients suffering from cancer and other diseases. The company's pipeline products include HPN424, HPN536, HPN217, and others.